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Aerobic and resistance exercise improve walking speed and endurance in people
with multiple sclerosisSynopsisSummary of: Pearson M, Dieberg G, Smart N. Exercise as
therapy for improvement of walking ability in adults withmultiple
sclerosis: A meta-analysis. Arch Phys Med Rehabil. 2015;96: 1339-
1348.
Objective: To quantify the beneﬁts of exercise for improving
walking speed and endurance in adults with multiple sclerosis.
Data [3_TD$DIFF]sources: PubMed, EMBASE, CINAHL, SPORTDiscus, and the
Cochrane Central Register of Controlled Trials, searched up to
March 31, 2014. This search was supplemented by searching
reference lists of retrieved publications. Study [4_TD$DIFF]selection: Random-
ised, controlled trials that compared exercise with no intervention
or waitlist control in ambulatory adults with multiple sclerosis,
with at least 10 subjects in the post-intervention analysis, and
published in English. Exercise intervention was deﬁned as aerobic
and endurance training, resistance training, aquatics and yoga.
Exercise involving treadmill, robot assistance, or other specialised
techniques (eg, functional electrical stimulation) were excluded.
Outcome measures for gait speed were the 10-m walk test, timed
25-foot walk test, and 500-m walk test; measures for endurance
were the 2-minute and 6-minute walk tests. Functional mobility
was assessed with the Timed Up and Go test. Data [5_TD$DIFF]extraction:
Study quality was assessed using a modiﬁed Physiotherapy
Evidence Database score (maximum score of 8). Data [6_TD$DIFF]synthesis:
Of the 437 studies initially identiﬁed by the search, 13 studies with
a total of 655 participants with multiple sclerosis (357 exercise,
298 controls) met selection criteria and were included in the
review. Quality assessment scores ranged from 5 to 8. Meta-1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).analysis demonstrated a statistically signiﬁcant difference in gait
speed in favour of exercise, based on the 10-m walk test ( [7_TD$DIFF]eight
intervention groups, MD –1.76 seconds, 95% CI [8_TD$DIFF] –2.47 to [9_TD$DIFF] –1.06) and
the 500-m walk test ([10_TD$DIFF]one intervention group, MD –0.31 seconds,
95% CI –0.59 to –0.03), but not the timed 25-foot walk (ﬁve
intervention groups, MD –0.59 seconds, 95% CI –2.55 to 1.36).
There was also a statistically signiﬁcant difference in walking
endurance in favour of exercise for both the 6-minute walk test
(four intervention groups, MD [11_TD$DIFF]36 m, 95% CI [12_TD$DIFF] 5 to [13_TD$DIFF]58) and the 2-
minute walk test (ﬁve intervention groups, MD [14_TD$DIFF] 2 m, 95% CI [15_TD$DIFF] to
[16_TD$DIFF]20). Differences in the Timed Up and Go test were not signiﬁcant
(ﬁve intervention groups, MD –1.05 seconds, 95% CI –2.19 to 0.09).
The strongest effects of exercise on gait speed were found for
interventions combining aerobic and resistance training, and for
interventions > 12 weeks in duration. Conclusion: Exercise inter-
ventions improvewalking speed (10-mwalk test, 500-mwalk test)
and endurance (2-minute and 6-minute walk tests) in people with
multiple sclerosis. Combination interventions may be optimal.
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http://dx.doi.org/10.1016/j.jphys.2015.12.006CommentaryWalking dysfunction is a common, life-altering feature of
multiple sclerosis. Accordingly, the improvement of walking
function is a major focus of ongoing rehabilitation research.
Physiological deconditioning (eg, aerobic capacity) is a primary
determinant of walking dysfunction in multiple sclerosis,1 and
exercise represents a behavioural approach for reversing decon-
ditioning and thereby improving ambulation. The meta-analysis
by Pearson and colleagues quantiﬁed the improvement in walking
performance across randomised, controlled trials of exercise in
multiple sclerosis. The meta-analysis included 13 trials and
suggested that exercise can improve walking speed, walking
endurance, and perhaps mobility (eg, Timed Up and Go test) in
people with multiple sclerosis.
This meta-analysis did not consider disease status or ﬁtness
adaptations as effect moderators. This is important for under-
standing if exercise is effective across the disease spectrum,
particularly considering that drugs are ineffective for slowing
eventual progression of mobility disability in moderate and severe
multiple sclerosis.2 The focus on ﬁtnesswould provide information
on changes in physiological functioning as possible mechanisms
for walking improvements.Overall, this meta-analysis provides estimates of exercise effects
on walking outcomes in multiple sclerosis. The results can inform
power analyses for future randomised, controlled trials and inform
clinical practice recommendations. Clinically, exercise is a consid-
erably less expensive option for managing walking outcomes in
multiple sclerosis than pharmacotherapy and can be prescribed as
part of ongoing, comprehensive multiple sclerosis care. There are
many beneﬁts of exercise in multiple sclerosis,3 and this meta-
analysis further underscores its importance for comprehensively
improvingoutcomes, includingwalking, in thisneurological disease.
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